Chemoinformaics analysis of 1,3,8-Trihydroxy-6-methoxy-2-methylanthraquinone
| Molecular Weight | 300.266 | nRot | 1 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 18 |
| Exact Molecular Weight | 300.063 | nRing | 3 |
| Solubility: LogS | -4.674 | nHRing | 0 |
| Solubility: LogP | 3.815 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 39.5335 |
| nHD | 3 | BPOL | 15.5105 |
| QED | 0.634 |
| Synth | 2.496 |
| Natural Product Likeliness | 1.576 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.092 |
| Pgp-sub | 0.005 |
| HIA | 0.139 |
| CACO-2 | -5.277 |
| MDCK | 0.0000105 |
| BBB | 0.015 |
| PPB | 1.00265 |
| VDSS | 0.382 |
| FU | 0.017926 |
| CYP1A2-inh | 0.901 |
| CYP1A2-sub | 0.855 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.576 |
| CYP2c9-sub | 0.372 |
| CYP2d6-inh | 0.127 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.461 |
| CYP3a4-sub | 0.136 |
| CL | 9.165 |
| T12 | 0.241 |
| hERG | 0.023 |
| Ames | 0.808 |
| ROA | 0.094 |
| SkinSen | 0.617 |
| Carcinogencity | 0.262 |
| EI | 0.95 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.514 |
| Antiviral | Yes |
| Prediction | 0.799244 |